Bracco Group takes centre stage at health and well-being week at Expo Osaka
Bracco Group is one of the leading participants at Expo Osaka. As a Gold Sponsor of the Italy Pavilion, Bracco, global leader in diagnostic imaging, is actively engaged in several key events during Health and Well-Being Week from 20 June 20 to 1 July.
The first event of Japan Health Week, which Bracco attended as a Strategic Partner, was the Agevity Forum, a meeting held in the Italian Pavilion dedicated to health, ageing, sustainability and longevity organized by Assolombarda and Silver Economy Network. The event was attended by Mario Vattani, Commissioner General for Italy at Expo 2025 Osaka; Gianluigi Serianni, Scientific and Technological Attaché, Italian Embassy in Tokyo; Ako Makiyama, Executive Director, Osaka Chamber of Commerce and Industry; and numerous world-renowned scientists, among them Professor Noriyuki Tsumaki of the Department of Biochemistry and Molecular Biology at the University of Osaka and Professor Nobuhiro Hayashi, Vice President of International Strategy and Engagement at the Institute of Science of Tokyo.
Andrea Mecenero, CEO of Centro Diagnostico Italiano was also a participant at the event: “Here at CDI, our strategic goal is to ensure a long, active, healthy, and high-quality life for today’s and tomorrow’s seniors. Prevention, healthy lifestyles, and early diagnostics are the three pillars we have been focusing on for 50 years, and we are proud to celebrate a half-century of activity in 2025.”
Bracco Group also participated in two events organized by the Italian Institute of Technology (IIT) on Health Technologies. The first, at the Italian Pavilion, was a workshop titled “Health Technologies: How Science is transforming Healthcare”, at which Bracco unveiled an innovative digital platform built with IIT called IPPOCRATE, which facilitates collaborative research by eliminating the need to transfer data between clinical centres. The second event was a symposium held at the Italian Embassy in Tokyo, where Isabella Castiglioni, Director of Research, Development and Innovation of the CDI, spoke in a panel discussion on “Robotics for health and Aging & Health technologies”.
Finally, during the same Health and Well-Being Week, Bracco Group organized a second event at the splendid Italy Pavilion at Expo Osaka to introduce Bracco Japan, just over a year since it was set up, to local healthcare professionals and the broader medical business community. With the closure of the previous joint venture and the transfer of operations to the new company, led by Tetsuaki Sakamoto, Bracco has embarked on an independent path as both a manufacturer and distributor of contrast agents. “Bracco has been present in Japan since 1992, initially through a successful joint venture,” explained Diana Bracco. “But to strengthen our presence, we have been operating directly with a fully autonomous new company since April 2024. Japan is a strategic market for us, particularly due to its widespread culture of prevention, supported by an advanced healthcare system, especially in the field of diagnostic imaging, and serving a notably long-lived population.”
“With Bracco Japan, we aim to reinforce our presence in the country by responding even more effectively to the needs of doctors and patients through increasingly advanced diagnostic imaging solutions that integrate contrast agents, cutting-edge technologies, and services—including injectors and other devices we manufacture, such as those from ACIST,” specified Fulvio Renoldi Bracco, Vice President and CEO of Bracco Imaging. “But our commitment goes further. In keeping with our tradition, we will continue to invest in medical innovation in Japan, and we have numerous new products in our development pipeline. We intend to build an increasingly active system of cooperation with the local radiological and scientific community by attending to their priorities and working with them to address the great health challenges of the future.”